The two sides will collaborate on surgical sutures of aortic valve replacement.
NeatStich Ltd. has signed a collaboration agreement with the US National Institutes of Health (NIH) to develop a device to be used in minimally invasive surgical sutures for heart surgeries. The two side will collaborate to develop a device for aortic valve replacement surgery. The product will be based on NeatStich's proprietary technology for automated port closure for laparoscopic surgery.
NeatStich has begun sales of its automated port closure device for laparoscopic surgery, NeatClose, in the US and in some European countries.
Xenia Venture Capital Ltd. (TASE:XENA) owns 27.72% of NeatStich. Virginia Life Sciences Investments LLC (VLSI) is also an investor.
Published by Globes [online], Israel business news - www.globes-online.com - on December 26, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010